Broker tips: Mondi, Inmarsat

Digital Look Sharecast | 17 Feb, 2017 12:50 | | |

Mondi

JPMorgan Cazenove upgraded paper and packaging company Mondi to ‘overweight’ from ‘neutral’ and lifted the price target to 2,070p from 1,600p.

The bank said it expects the tightening in Mondi’s key markets and rising old corrugate container/pulp input costs – from which Mondi derives net benefit as a mostly integrated producer – to support price hikes from the second quarter.

This drives upgrades of around 6% to its FY17 earnings per share forecasts and 3% to FY18 estimates.

JPM pointed out that Mondi’s key markets are tightening on the back of strong demand, limited near-term capacity additions and lack of spare capacity in the US (a major exporter into Europe), assisted by rising input costs.

“Moreover, we expect Mondi’s balance sheet to continue to offer optionality in the form of further M&A or cash returns, given low levels of leverage.

“On 14.3x FY17e price to earnings, some of the improved outlook is priced in, but Mondi tends to rerate in a price hiking cycle and, in a reflationary environment, we think there will be more to go given improved pricing power.”

Inmarsat

Analysts at UBS slashed their target price on stock of Inmarsat on expectations the company would stop increasing its dividend payout.

Inmarsat would do so - possibly beginning with its fiscal year 2016 numbers - until the divi was covered by its equity free cash flow, the Swiss broker said.

Markets on the other hand expected it to continue growing it in 2017 at a clip similar to that projected by the consensus of between 4% and 5%.

On a more positive note, that would allow Inmarsat to invest in long-term opportunities and avoid undue pressure on the balance sheet while its EFCF was "limited and uncertain".

UBS also expected Inmarsat to lower its fiscal year 2018 revenue guidance.

The analysts cut their target price on the shares from 810p to 550p and slapped a 'sell' recommendation on the stock, down from 'neutral'.

More news

10:44 Analysts say RBS's new plans bring dividend closer, lift earnings potential

If Royal Bank of Scotland retains the Williams & Glyn business, as proposed, it will bring a return to dividends closer and lift earnings in 2019, according to analysts at Morgan Stanley, JP Morgan Cazenove and others on Monday.

10:39 Kraft Heinz ditches Unilever takeover plans

Kraft Heinz has ditched its plans to take over Unilever, just two days after it emerged the London-listed consumer goods giant had rejected a $143bn offer.

10:37 Beowulf Mining says no news on Kallak North

Beowulf Mining noted the recent rise in its share price and comments over the weekend by the chief mining inspector in Finland, who said she hoped there would be clarity this week over which direction the process for the award of the exploitation concession for Kallak North was heading.

10:35 Condor Gold planning £5.24m fundraising to develop Nicaragua mine

Condor Gold plans to raise £5.24m in share placing and director's subscription to further develop its mine in Nicaragua.

10:29 Proactis Holdings anticipates a 36% rise in H1 revenue

AIM-listed procurement solution provider Proactis Holdings anticipates that results for the first half of the year will be in line with expectations with a rise in revenue.

10:22 BGEO Group rapid profits growth slowed by Georgian currency slide

BGEO Group, the Georgian banking and healthcare group, revealed 2016 profits and earnings rose strongly even though they were held back by a decline in the fourth-quarter.

10:22 JP Morgan downgrades StanChart, saying imperfect play on US rates

Analysts at JP Morgan downgraded their recommendation on StanChart stock, emphasising that its shares were an "imperfect play" on the US interest rate cycle and how the 'bullish' scenario for the shares required a medium-term perspective.

10:19 WPP buys stake in Ireland's Eightytwenty

WPP’s marketing communications network, Ogilvy & Mather, has acquired a stake in its digital partner in Ireland, Eightytwenty.

10:07 One Media considers options after court vacates infringement judgement

Digital media content provider One Media iP Group updated the market on its claims in the US that its music rights had been exploited without authorisation.

10:07 Ergomed's Swedish drug development partner raises £2.9m

AIM-listed pharmaceutical Ergomed’s Stockholm-based development partner Modus Therapeutics has raised £2.9m (32m Swedish krona) to support a phase two study of a sickle cell drug.